To evaluate a topical HIV prevention product using a nonhuman primate, repeat low dose model to define activity and toxicity of an intravaginal ring product.
To facilitate the formation of a HIV Trials Network to advance research, therapy and prevention. If the interventions in the clinical trials are determined safe and effective, they will add to the options available to prevent and control these diseases of global significance.
To strengthen vaccine-preventable disease surveillance platforms to maximize their capacity to measure burden of disease and to monitor the impact of vaccines. Activities include improving immunization data quality; evaluating impact and implementation of vaccines (including oral cholera, rubella, and HPV); improving the quality and planning of measles and rubella campaigns; and strengthening surveillance for vaccine preventable diseases (meningitis, diphtheria and pertussis, intussusception).
GAVI
CDC's National Center for Immunization and Respiratory Diseases
To facilitate formation of a Clinical Trials Unit for HIV/AIDS and tuberculosis research to advance therapy and prevention. If the interventions in the clinical trials are determined safe and effective, they will add to the options available to prevent and control these diseases of global significance.
Emory University (National Institutes of Health)
CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
To provide substance use and HIV prevention education, access to health services, safe and supportive environments and monitoring and evaluation for high-risk communities in Kentucky, Ohio and Indiana.
Conrad Hilton Foundation
CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
To explore the effectiveness of opt-out chlamydia screening via electronic health record prompt and to increase the percentage of women under the age of 25 who are screened for chlamydia at clinical encounters.
Hologic, Inc.
CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention; University of Pittsburgh
To reduce potentially deadly bloodstream infections in hemodialysis outpatients by targeting patients, healthcare providers and caregivers using evidence-based communications strategies with prevention messages.
Amgen
CDC's National Center for Emerging and Zoonotic Infectious Diseases